Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-0122

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 0409-0122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daptomycin 01)

Chemical structure diagram of daptomycin, showing its complex cyclic lipopeptide molecular architecture with amino acid and lipid components.*

FDA Label Image

Logo (Daptomycin 02)

FDA Label Image

Principal Display Panel (500 mg Vial Label)

Label for Daptomycin injection, powder, lyophilized for solution, 500 mg per vial by Hospira, Inc. It states 'Must be reconstituted' and 'For Intravenous Use,' with storage instructions at 2°C to 25°C (36°F to 77°F) and a note to discard unused portions. The label includes barcode information, lot number and expiration date placeholders, and manufacturer details.*

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Packaging label for Daptomycin for Injection 500 mg per vial, a lyophilized powder for intravenous use. The label includes instructions for reconstitution with 0.9% Sodium Chloride Injection and states single-dose vial with unused portion to be discarded. The product is labeled by Hospira, Inc., featuring a purple and black color scheme with barcode and storage information.*

FDA Label Image

Principal Display Panel (350 mg Vial Label)

Label for Daptomycin injection, 350 mg per vial, lyophilized powder for intravenous use. Includes storage instructions (2°C to 25°C, do not freeze), reconstitution with 7 mL of 0.9% Sodium Chloride Injection USP, single dose vial, and discard unused portion. Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. Contains barcode and NDC 0409-0120-01.*

FDA Label Image

Principal Display Panel (350 mg Vial Carton)

Packaging label for Daptomycin for Injection, 350 mg per vial, a lyophilized powder for intravenous use. The label highlights reconstitution instructions and storage information. Manufactured by Hospira, Inc., the label features a purple and white color scheme with barcode and lot information sections.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.